See more : Beijing Transtrue Technology Inc. (002771.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Japan Tobacco Inc. (JAPAY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Japan Tobacco Inc., a leading company in the Tobacco industry within the Consumer Defensive sector.
You may be interested
- InfoBeans Technologies Limited (INFOBEAN.NS) Income Statement Analysis – Financial Results
- California Nanotechnologies Corp. (CANOF) Income Statement Analysis – Financial Results
- Linus Digital Finance AG (LDF.F) Income Statement Analysis – Financial Results
- Great-West Lifeco Inc. (GWO.TO) Income Statement Analysis – Financial Results
- Sysmex Corporation (SSMXF) Income Statement Analysis – Financial Results
Japan Tobacco Inc. (JAPAY)
About Japan Tobacco Inc.
Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, prescription drugs, and processed foods in Japan and internationally. The company operates through four segments: Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food. It offers tobacco products, such as cigarettes, cigars, pipe tobacco, oral tobacco, waterpipe tobacco, kretek, and fine cut products under the Winston, Camel, MEVIUS, and LD brands. The company also provides reduced-risk products, including tobacco-infused vapor and heated tobacco products, E-Vapor products, etc. under the Ploom, Logic, Ploom TECH, Ploom TECH+, and Ploom S brands. In addition, it researches and develops, manufactures, and sells prescription drugs for the therapeutic areas, such as cardiovascular, renal and metabolism, immunology, and neuroscience. Further, the company provides staple food products, such as frozen noodles and okonomiyaki, and frozen and packed cooked rice; ambient processed foods; bakery products; and seasonings, including yeast extracts and oyster sauce. Japan Tobacco Inc. was founded in 1898 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,841.08B | 2,657.83B | 2,324.84B | 2,092.56B | 2,175.63B | 2,215.96B | 2,139.65B | 2,143.29B | 2,252.88B | 2,019.75B | 2,399.84B | 2,120.20B | 2,033.83B | 6,194.55B | 6,134.70B | 6,832.31B | 6,409.73B | 4,769.39B | 4,637.66B | 4,664.51B | 4,625.15B | 4,492.26B | 4,544.18B |
| Cost of Revenue | 1,225.97B | 1,090.99B | 956.86B | 898.00B | 942.30B | 933.03B | 843.56B | 872.43B | 920.06B | 822.54B | 979.98B | 899.44B | 892.03B | 5,074.07B | 5,022.64B | 5,554.40B | 5,228.93B | 3,844.77B | 3,734.07B | 3,713.73B | 3,684.01B | 3,569.39B | 3,598.80B |
| Gross Profit | 1,615.10B | 1,566.84B | 1,367.98B | 1,194.56B | 1,233.33B | 1,282.93B | 1,296.10B | 1,270.85B | 1,332.83B | 1,197.21B | 1,419.87B | 1,220.76B | 1,141.79B | 1,120.48B | 1,112.06B | 1,277.91B | 1,180.80B | 924.62B | 903.58B | 950.79B | 941.14B | 922.87B | 945.38B |
| Gross Profit Ratio | 56.85% | 58.95% | 58.84% | 57.09% | 56.69% | 57.89% | 60.58% | 59.29% | 59.16% | 59.28% | 59.17% | 57.58% | 56.14% | 18.09% | 18.13% | 18.70% | 18.42% | 19.39% | 19.48% | 20.38% | 20.35% | 20.54% | 20.80% |
| Research & Development | 0.00 | 70.81B | 65.02B | 60.85B | 64.08B | 65.38B | 60.60B | 58.19B | 57.80B | 58.68B | 57.10B | 56.86B | 51.46B | 48.87B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 981.05B | 941.54B | 888.57B | 784.47B | 831.71B | 770.41B | 786.91B | 754.12B | 789.35B | 752.56B | 828.94B | 733.49B | 27.92B | 791.80B | 815.55B | 914.10B | 750.25B | 592.63B | 596.64B | 677.42B | 707.10B | 733.91B | 781.57B |
| Selling & Marketing | 0.00 | 233.37B | 204.84B | 177.02B | 191.03B | 188.06B | 218.03B | 228.53B | 224.10B | 255.18B | 218.82B | 199.20B | 190.50B | 195.03B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 981.05B | 941.54B | 888.57B | 784.47B | 831.71B | 770.41B | 786.91B | 754.12B | 789.35B | 752.56B | 828.94B | 733.49B | 218.42B | 791.80B | 815.55B | 914.10B | 750.25B | 592.63B | 596.64B | 677.42B | 707.10B | 733.91B | 781.57B |
| Other Expenses | -38.36B | -20.26B | -15.62B | -54.92B | -95.73B | -48.53B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 293.61B | 0.00 | -5.74B | -47.58B | -65.35B | 0.00 | 0.00 | 0.00 | -53.11B | -44.62B | -77.75B |
| Operating Expenses | 942.69B | 921.28B | 872.95B | 729.55B | 735.98B | 721.88B | 741.19B | 684.01B | 773.98B | 752.56B | 773.31B | 691.32B | 563.49B | 791.80B | 815.55B | 914.10B | 750.25B | 592.63B | 596.64B | 677.42B | 707.10B | 733.91B | 781.57B |
| Cost & Expenses | 2,168.67B | 2,012.27B | 1,829.81B | 1,627.55B | 1,678.28B | 1,654.91B | 1,584.75B | 1,556.45B | 1,694.04B | 1,575.10B | 1,753.28B | 1,590.76B | 1,455.53B | 5,865.87B | 5,838.19B | 6,468.50B | 5,979.17B | 4,437.40B | 4,330.71B | 4,391.14B | 4,391.12B | 4,303.30B | 4,380.37B |
| Interest Income | 44.41B | 31.15B | 19.01B | 12.35B | 8.40B | 5.75B | 4.78B | 6.62B | 15.02B | 13.81B | 8.35B | 5.49B | 5.60B | 3.03B | 6.98B | 12.28B | 13.41B | 12.10B | 0.00 | 3.32B | 3.24B | 3.74B | 4.70B |
| Interest Expense | 95.22B | 91.27B | 45.65B | 61.34B | 45.53B | 39.25B | 27.35B | 21.71B | 15.13B | 11.16B | 20.41B | 28.35B | 23.43B | 17.06B | 26.11B | 51.36B | 41.76B | 6.94B | 5.78B | 5.15B | 8.14B | 8.55B | 10.27B |
| Depreciation & Amortization | 179.65B | 199.37B | 187.00B | 179.29B | 183.32B | 158.10B | 144.84B | 140.15B | 139.06B | 122.17B | 132.92B | 116.46B | 118.85B | 212.76B | 230.20B | 282.41B | 171.54B | 132.64B | 126.45B | 126.74B | 153.59B | 148.33B | 170.31B |
| EBITDA | 824.78B | 836.31B | 673.86B | 661.06B | 694.61B | 680.32B | 711.29B | 740.74B | 719.30B | 635.86B | 789.53B | 654.17B | 583.63B | 529.15B | 532.36B | 595.91B | 585.91B | 445.54B | 433.21B | 458.07B | 337.76B | 299.38B | 278.83B |
| EBITDA Ratio | 29.03% | 33.27% | 30.33% | 31.59% | 31.93% | 32.92% | 33.24% | 34.56% | 31.93% | 29.13% | 32.90% | 30.85% | 34.55% | 8.79% | 8.61% | 8.94% | 8.58% | 9.34% | 9.27% | 9.82% | 7.30% | 6.60% | 5.75% |
| Operating Income | 672.41B | 653.58B | 499.02B | 469.05B | 502.36B | 564.98B | 561.10B | 593.33B | 565.23B | 466.27B | 648.26B | 532.21B | 408.62B | 328.68B | 296.51B | 363.81B | 430.55B | 312.90B | 306.95B | 273.37B | 234.03B | 148.08B | 163.81B |
| Operating Income Ratio | 23.67% | 24.59% | 21.46% | 22.42% | 23.09% | 25.50% | 26.22% | 27.68% | 25.09% | 23.09% | 27.01% | 25.10% | 20.09% | 5.31% | 4.83% | 5.32% | 6.72% | 6.56% | 6.62% | 5.86% | 5.06% | 3.30% | 3.60% |
| Total Other Income/Expenses | -50.81B | -60.13B | -26.63B | -48.99B | -37.12B | -33.50B | -22.57B | -15.09B | -116.00M | 57.88B | -12.06B | -22.86B | -17.83B | 56.56B | -20.45B | -101.66B | -57.94B | 5.21B | -5.95B | -172.04B | -241.64B | -5.59B | -65.56B |
| Income Before Tax | 621.60B | 593.45B | 472.39B | 420.06B | 465.23B | 531.49B | 538.53B | 578.24B | 565.11B | 502.53B | 636.20B | 509.36B | 441.36B | 280.50B | 276.06B | 262.14B | 372.61B | 337.20B | 300.99B | 101.33B | -7.61B | 142.50B | 98.24B |
| Income Before Tax Ratio | 21.88% | 22.33% | 20.32% | 20.07% | 21.38% | 23.98% | 25.17% | 26.98% | 25.08% | 24.88% | 26.51% | 24.02% | 21.70% | 4.53% | 4.50% | 3.84% | 5.81% | 7.07% | 6.49% | 2.17% | -0.16% | 3.17% | 2.16% |
| Income Tax Expense | 136.29B | 149.28B | 132.21B | 108.03B | 103.61B | 144.06B | 141.78B | 152.46B | 162.39B | 132.81B | 200.91B | 157.91B | 112.80B | 130.89B | 131.30B | 134.97B | 128.38B | 121.41B | 94.90B | 31.57B | -4.81B | 61.81B | 56.73B |
| Net Income | 482.29B | 442.72B | 338.49B | 310.25B | 348.19B | 385.68B | 392.41B | 421.70B | 485.69B | 362.92B | 427.99B | 343.60B | 320.88B | 144.96B | 138.45B | 123.40B | 238.70B | 210.77B | 201.54B | 62.58B | -7.60B | 75.30B | 36.85B |
| Net Income Ratio | 16.98% | 16.66% | 14.56% | 14.83% | 16.00% | 17.40% | 18.34% | 19.68% | 21.56% | 17.97% | 17.83% | 16.21% | 15.78% | 2.34% | 2.26% | 1.81% | 3.72% | 4.42% | 4.35% | 1.34% | -0.16% | 1.68% | 0.81% |
| EPS | 271.63 | 249.45 | 190.76 | 174.88 | 195.97 | 107.65 | 109.55 | 117.74 | 135.27 | 99.84 | 117.74 | 90.54 | 84.25 | 37.85 | 36.13 | 32.20 | 62.29 | 55.00 | 262.71 | 80.22 | -1.98 | 18.76 | 9.21 |
| EPS Diluted | 271.63 | 249.36 | 190.68 | 174.80 | 195.87 | 107.60 | 109.49 | 117.67 | 135.19 | 99.78 | 117.68 | 90.49 | 84.22 | 37.84 | 36.12 | 32.20 | 62.29 | 55.00 | 262.71 | 80.22 | -1.98 | 18.76 | 9.21 |
| Weighted Avg Shares Out | 1.78B | 1.77B | 1.77B | 1.77B | 1.78B | 3.58B | 3.58B | 3.58B | 3.59B | 3.64B | 3.64B | 3.80B | 3.81B | 3.83B | 3.83B | 3.83B | 3.83B | 3.83B | 3.83B | 3.83B | 3.83B | 3.83B | 4.00B |
| Weighted Avg Shares Out (Dil) | 1.78B | 1.78B | 1.78B | 1.77B | 1.78B | 3.58B | 3.58B | 3.58B | 3.59B | 3.64B | 3.64B | 3.80B | 3.81B | 3.83B | 3.83B | 3.83B | 3.83B | 3.83B | 3.83B | 3.88B | 3.83B | 4.01B | 4.00B |
E-cig startup Juul is talking to Philip Morris, Altria, and Japan Tobacco about its future, WSJ reports. Here's a rundown of the startup's rise and fall.
Juul rebranded three times, sold assets, and attracted nontraditional investors. Now, it's reportedly in partnership talks with big tobacco companies.
Japan Tobacco Inc. (JAPAF) Q1 2023 Earnings Call Transcript
Japan Tobacco Inc. (OTCPK:JAPAF) Q1 2023 Earnings Conference Call May 2, 2023 4:00 AM ET Company Participants Nobuya Kato - Chief Financial Officer Koji Shimayoshi - JTI, Deputy Chief Executive Officer Conference Call Participants Hiroshi Saji - Mizuho Securities Satoshi...
If I Could Only Buy 2 Dividend Stocks In April 2023
In today's article, I will introduce you to my two top dividend picks of the month, which I currently consider attractive due to various factors. Both companies have strong financial health, possess important competitive advantages and their valuation is currently...
Altria Vs. Japan Tobacco: Which Company Is The Best Investment For 2023?
Altria and Japan Tobacco have identical annual revenue. Altria and Japan Tobacco have entered into an agreement to sell JAPAY's HTS (Heated Tobacco Stick) Ploom X in the US.
Japan Tobacco Inc. (JAPAF) Q4 2022 Earnings Call Transcript
Japan Tobacco Inc. (OTCPK:JAPAF) Q4 2022 Earnings Conference Call February 15, 2023 4:00 AM ET Company Participants Masamichi Terabatake - Chief Executive Officer Eddy Pirard - Chief Executive Officer of JT International Nobuya Kato - Chief Financial Officer Vassilis Vovos...
Juul in Deal Talks With Three Tobacco Giants
The e-cigarette maker is exploring a potential sale, investment or distribution deal with Philip Morris, Japan Tobacco or Altria.
Is It Time to Dive Back into Stocks?
The strength in the economy indicates that Fed actions will continue, so it's better to go for safer stocks.
Japan Tobacco: Fade The ~7% Yield
Japan Tobacco delivers a beat-and-raise quarter. The dividend has been hiked as well.
Japan Tobacco Inc. (JAPAF) Q3 2022 Earnings Call Transcript
Japan Tobacco Inc. (OTCPK:JAPAF) Q3 2022 Earnings Conference Call October 31, 2022 4:00 AM ET Company Participants Nobuya Kato - Chief Financial Officer Koji Shimayoshi - Executive Vice President and Deputy Chief Executive Officer Conference Call Participants Nobuyoshi Miura -...
Japan Tobacco Inc. (JAPAF) Management on Q2 2022 Results - Earnings Call Transcript
Japan Tobacco Inc. (OTCPK:JAPAF) Q2 2022 Earnings Conference Call July 29, 2022 5:00 AM ET Company Participants Nobuya Kato - CFO Koji Shimayoshi - Deputy Chief Executive Officer Conference Call Participants Nobuyoshi Miura - Citigroup Global Markets Japan Hiroshi Saji...
Source: https://incomestatements.info
Category: Stock Reports